Cyprotex nonplussed by price slump

CHESHIRE biotech firm Cyprotex said today it did not know why its share price has fallen sharply.

Shares in the Macclesfield firm have fallen as much as a third – from 3.5p last Wednesday to as low as 2.5p yesterday, but recovered 4% this morning.

In a brief statement the AIM-listed firm said said current trading was in line with market expectations.

The firm added that it would provide a trading update towards the end of this month, covering the year to December 31.